Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
Open Access
- 15 June 2020
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 12 (6) , 604-618
Abstract
Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancerKeywords
This publication has 123 references indexed in Scilit:
- Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric studyAnnals of Oncology, 2013
- Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon CancerJAMA, 2012
- Comparison of adverse events during 5‐fluorouracil versus 5‐fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancerCancer, 2012
- Screening older cancer patients: first evaluation of the G-8 geriatric screening toolAnnals of Oncology, 2012
- Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled TrialsJournal of General Internal Medicine, 2011
- Adjuvant Chemotherapy Use and Adverse Events Among Older Patients With Stage III Colon CancerJAMA, 2010
- Older adults and cancer treatmentCancer, 2008
- A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancerBritish Journal of Cancer, 2007
- A pilot study of the vulnerable elders survey‐13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablationCancer, 2007
- Completion of Therapy by Medicare Patients With Stage III Colon CancerJNCI: Journal of the National Cancer Institute, 2006